4.5 Review

Schistosome sirtuins as drug targets

期刊

FUTURE MEDICINAL CHEMISTRY
卷 7, 期 6, 页码 765-782

出版社

FUTURE SCI LTD
DOI: 10.4155/FMC.15.24

关键词

-

资金

  1. European Union's Seventh Framework Programme for research, technological development and demonstration [241865, 602080]
  2. institutional funds from the Centre National de la Recherche Scientifique (CNRS)
  3. Institut National de la Sante et de la Recherche Medicale (INSERM)
  4. Universite de Strasbourg and the Universite de Lille 2
  5. French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]
  6. Instruct (ESFRI)
  7. Deutsche Forschungsgemeinschaft [P10, RTG1976]

向作者/读者索取更多资源

The sirtuins form a superfamily of evolutionarily conserved NAD(+)-dependent protein N-epsilon-acyl-lysine (AcK) deacylases with roles in a variety of key cellular processes. Sirtuins have a broadly conserved overall structure with a catalytic site formed by a hydrophobic channel between the NAD(+)-binding Rossmann fold domain and a smaller Zn2+-binding domain. Schistosomes express five members of the sirtuin family and generic sirtuin inhibitors induce apoptosis and death in schistosome larvae, the disruption of adult worm pairs, inhibition of egg laying and damage to the male and female worm reproductive systems. Sirtuins in schistosomes and other parasitic flatworms present structural differences from their human orthologues that should allow the development of selective inhibitors that can be developed as drug leads.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据